Fresh analysis indicates that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who stop conventional diet and exercise plans.
Research printed in a prominent medical journal points out that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such treatments need to be informed of the risk of fast rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment weight in about one and a half years.
Comparing Treatments
The study, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with older methods.
Scientists note that individuals who lose weight through diet and exercise generally experience a more gradual creep back—approximately 100 grams monthly—once they finish.
The Reason for the Quick Regain
Doctors believe the way of the injections accounts for the heightened rebound.
The injections copy a natural hormone called GLP-1, which helps regulate appetite.
"Long-term administration of the hormone levels several times higher than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is unsuppressed, making binge eating far more likely."
A Lifelong Issue?
Medical guidelines suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, given the high risk of weight regain, the treatment is often long-term.
This opinion is supported by drug manufacturers, who note that the findings "highlight the chronic character of obesity," comparing it to managing conditions like hypertension.
User Testimonies
People who have stopped the medication explain a sudden return of cravings.
"It was like a trigger activating and you become extremely hungry," described one woman.
The struggle is compounded if patients have not developed sustainable lifestyle or habit changes during treatment.
Widespread Use
Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is greater among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent cure and maintained weight loss relies on combined lifestyle management.
